You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Blinatumomab for previously treated Philadelphia-chromosome-negative acute lymphoblastic leukaemia

  • Technology appraisal guidance
  • Reference number: TA450
  • Published:  28 June 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Final appraisal determination
  2. Invitation to participate

History

A list of downloadable documents created during development.

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 413 KB)

    Published:
    27 April 2017
  • Public committee slides (PDF 478 KB)

    Published:
    27 April 2017
  • Public committee slides (PowerPoint 2.18 MB)

    Published:
    16 May 2017
  • Committee papers (PDF 10.59 MB)

    Published:
    29 May 2017

Invitation to participate

  • NICE's response to comments on the draft scope and provisional matrix (PDF 234 KB)

    Published:
    14 March 2017
  • Equality impact assessment (Scoping) (PDF 175 KB)

    Published:
    14 March 2017
  • Final scope (PDF 112 KB)

    Published:
    14 March 2017
  • Final matrix (PDF 99 KB)

    Published:
    14 March 2017
Back to top